
Sarah is developing technologies to study the contribution of aberrant DNA methylation to tumor pathogenesis
- MD/PhD student in Harvard-MIT MD/PhD Program
- Health Sciences and Technology (HST) Program at Harvard Medical School
- Systems Biology PhD program